Travere
Travere sells prescription medicines for rare kidney and metabolic diseases, so it earns its revenue from patients' treatment rather than from building the drugs' underlying science or the hospitals that deliver them.
Checked against the company's own business description in its latest annual filing.
Latest disclosed
10-Q filed 2026-08-04 · period ending 2026-06-30
Pieces naming this company
None yet.
No price is shown: the Index is a map of what each company sells and where it sits, not a quote board.